This whitepaper describes the role of non-polar and polar lipids in the tear film, compositional and physical changes in meibomian gland dysfunction, and first-line and mainstay therapy options for managing those changes and symptoms in MGD patients, including with BlephEx, Systane iLux, and Systane COMPLETE.